H19, H19 imprinted maternally expressed transcript, 283120
N. diseases: 242; N. variants: 15
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.776 | 0.280 | 11 | 1995389 | non coding transcript exon variant | A/G | snv | 0.42 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | < 0.001 | 2 | 2016 | 2019 | |||||||
|
0.776 | 0.280 | 11 | 1995389 | non coding transcript exon variant | A/G | snv | 0.42 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | < 0.001 | 2 | 2016 | 2019 | |||||||
|
0.641 | 0.480 | 11 | 1995678 | non coding transcript exon variant | G/A | snv | 0.20 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.010 | < 0.001 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.080 | 11 | 1998266 | intron variant | C/A | snv |
|
Nervous System Diseases; Cardiovascular Diseases | 0.010 | < 0.001 | 1 | 2018 | 2018 | ||||||||
|
0.882 | 0.080 | 11 | 2001574 | upstream gene variant | A/G | snv |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | < 0.001 | 1 | 2018 | 2018 | ||||||||
|
0.882 | 0.080 | 11 | 2001574 | upstream gene variant | A/G | snv |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | < 0.001 | 1 | 2018 | 2018 | ||||||||
|
0.882 | 0.080 | 11 | 2001574 | upstream gene variant | A/G | snv |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | < 0.001 | 1 | 2018 | 2018 | ||||||||
|
0.662 | 0.520 | 11 | 1997623 | non coding transcript exon variant | G/A | snv | 0.41 |
|
Eye Diseases; Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases; Stomatognathic Diseases | 0.010 | < 0.001 | 1 | 2017 | 2017 | |||||||
|
0.662 | 0.520 | 11 | 1997623 | non coding transcript exon variant | G/A | snv | 0.41 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | < 0.001 | 1 | 2020 | 2020 | |||||||
|
0.662 | 0.520 | 11 | 1997623 | non coding transcript exon variant | G/A | snv | 0.41 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.010 | < 0.001 | 1 | 2017 | 2017 | |||||||
|
0.776 | 0.280 | 11 | 1995389 | non coding transcript exon variant | A/G | snv | 0.42 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | < 0.001 | 1 | 2018 | 2018 | |||||||
|
0.925 | 0.160 | 11 | 2003453 | upstream gene variant | C/A | snv |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | < 0.001 | 1 | 2020 | 2020 | ||||||||
|
0.641 | 0.480 | 11 | 1995678 | non coding transcript exon variant | G/A | snv | 0.20 |
|
Neoplasms | 0.020 | 0.500 | 2 | 2019 | 2019 | |||||||
|
0.641 | 0.480 | 11 | 1995678 | non coding transcript exon variant | G/A | snv | 0.20 |
|
Neoplasms; Nervous System Diseases | 0.020 | 0.500 | 2 | 2019 | 2019 | |||||||
|
0.641 | 0.480 | 11 | 1995678 | non coding transcript exon variant | G/A | snv | 0.20 |
|
Neoplasms | 0.020 | 0.500 | 2 | 2019 | 2019 | |||||||
|
0.662 | 0.520 | 11 | 1997623 | non coding transcript exon variant | G/A | snv | 0.41 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.020 | 0.500 | 2 | 2017 | 2017 | |||||||
|
0.662 | 0.520 | 11 | 1997623 | non coding transcript exon variant | G/A | snv | 0.41 |
|
Neoplasms; Nervous System Diseases | 0.020 | 0.500 | 2 | 2019 | 2019 | |||||||
|
0.662 | 0.520 | 11 | 1997623 | non coding transcript exon variant | G/A | snv | 0.41 |
|
Neoplasms | 0.020 | 0.500 | 2 | 2019 | 2019 | |||||||
|
0.662 | 0.520 | 11 | 1997623 | non coding transcript exon variant | G/A | snv | 0.41 |
|
Neoplasms | 0.020 | 0.500 | 2 | 2019 | 2019 | |||||||
|
0.776 | 0.200 | 11 | 1996209 | non coding transcript exon variant | C/G;T | snv | 0.46; 5.2E-06 |
|
Neoplasms; Nervous System Diseases | 0.020 | 0.500 | 2 | 2019 | 2019 | |||||||
|
0.776 | 0.200 | 11 | 1996209 | non coding transcript exon variant | C/G;T | snv | 0.46; 5.2E-06 |
|
Neoplasms | 0.020 | 0.500 | 2 | 2019 | 2019 | |||||||
|
0.776 | 0.200 | 11 | 1996209 | non coding transcript exon variant | C/G;T | snv | 0.46; 5.2E-06 |
|
Neoplasms | 0.020 | 0.500 | 2 | 2019 | 2019 | |||||||
|
0.732 | 0.280 | 11 | 1999845 | intron variant | C/T | snv |
|
Neoplasms | 0.030 | 0.667 | 3 | 2016 | 2017 | ||||||||
|
0.732 | 0.280 | 11 | 1999845 | intron variant | C/T | snv |
|
Neoplasms | 0.030 | 0.667 | 3 | 2016 | 2017 | ||||||||
|
0.641 | 0.480 | 11 | 1995678 | non coding transcript exon variant | G/A | snv | 0.20 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.040 | 0.750 | 4 | 2016 | 2019 |